|
covid-19 |
31 |
|
sars-cov-2 |
30 |
|
sars-cov |
29 |
|
viral replication |
22 |
|
influenza a virus |
19 |
|
coronavirus |
17 |
|
hemagglutinin |
16 |
|
animal experiment |
14 |
|
antiviral |
14 |
|
immune activation |
14 |
|
intestine |
14 |
|
mers-cov |
14 |
|
pathogenicity |
14 |
|
replication |
14 |
|
cytokine and chemokine response |
13 |
|
disease outbreaks |
13 |
|
influenza virus |
13 |
|
interferon |
13 |
|
pathogenesis |
13 |
|
mice |
12 |
|
animal cell |
11 |
|
animal tissue |
11 |
|
anthranilic acid |
11 |
|
bat |
11 |
|
broad spectrum |
11 |
|
coronavirus disease 2019 |
11 |
|
endoplasmic reticulum |
11 |
|
feces analysis |
11 |
|
human immunodeficiency virus |
11 |
|
mouse |
11 |
|
murine |
11 |
|
n501y |
11 |
|
rat |
11 |
|
sars-cov-2 variants |
11 |
|
susceptibility |
11 |
|
adaptation |
10 |
|
antigen-presentation |
10 |
|
coronavirus - immunology - pathogenicity - physiology |
10 |
|
coronavirus infections - immunology - virology |
10 |
|
cytokines - biosynthesis - immunology |
10 |
|
d222g |
10 |
|
d225g |
10 |
|
h1n1 |
10 |
|
hemagglutinin glycoproteins, influenza virus - genetics - metabolism |
10 |
|
human neutralizing antibody |
10 |
|
influenza |
10 |
|
influenza a virus, h1n1 subtype - genetics - pathogenicity |
10 |
|
influenza, human - epidemiology - virology |
10 |
|
lung injury |
10 |
|
mutation - genetics |
10 |
|
nasal turbinate |
10 |
|
omicron |
10 |
|
pandemic |
10 |
|
phage display |
10 |
|
pneumonia, viral - immunology - virology |
10 |
|
polymorphism, single nucleotide |
10 |
|
receptor binding domain |
10 |
|
sialic acid |
10 |
|
upper respiratory tract |
10 |
|
virus replication - physiology |
10 |
|
aged mice |
9 |
|
airway organoid |
9 |
|
animal model |
9 |
|
antibody-dependent cell-mediated cytotoxicity |
9 |
|
bagg albino mouse |
9 |
|
clinical outcome |
9 |
|
controlled study |
9 |
|
ex vivo |
9 |
|
genome mutation |
9 |
|
h1n1 influenza virus |
9 |
|
human primary nasal epithelial cells |
9 |
|
human respiratory syncytial virus |
9 |
|
humans |
9 |
|
infectivity |
9 |
|
lethal mouse model |
9 |
|
lung damage |
9 |
|
lung pathology |
9 |
|
pb2 |
9 |
|
post-ba.2/5 subvariants |
9 |
|
proximal differentiation |
9 |
|
transmission |
9 |
|
weanling mice |
9 |
|
2009 h1n1 influenza |
8 |
|
antibody detection |
8 |
|
apoptosis |
8 |
|
caspase |
8 |
|
dendritic cells |
8 |
|
female |
8 |
|
flavivirus |
8 |
|
ganglioside gm1 antibody |
8 |
|
genetic predisposition to disease |
8 |
|
hepatitis b virus |
8 |
|
influenza vaccine |
8 |
|
inhibitor |
8 |
|
male |
8 |
|
marmosets |
8 |
|
ns5 |
8 |
|
spleen |
8 |
|
t lymphocytes |
8 |
|
tonsil |
8 |
|
a(h1n1)pdm09 influenza |
7 |
|
a(h7n9) influenza |
7 |
|
alleles |
7 |
|
anti-influenza |
7 |
|
cross-protection |
7 |
|
cva16 |
7 |
|
ev-a71 |
7 |
|
furin cleavage prra motif |
7 |
|
genetic variation |
7 |
|
h7n7 virus |
7 |
|
hbv infection |
7 |
|
hepatitis b, chronic - genetics - immunology - metabolism |
7 |
|
ifnar1 |
7 |
|
immune response |
7 |
|
immunology |
7 |
|
intestinal organoids |
7 |
|
ire1 |
7 |
|
lung eqtl |
7 |
|
macrophages |
7 |
|
mdms |
7 |
|
modcs |
7 |
|
mutation |
7 |
|
neurogenesis |
7 |
|
pa protein |
7 |
|
polymerase assembly |
7 |
|
promoter regions, genetic |
7 |
|
receptor, interferon alpha-beta - genetics |
7 |
|
snp |
7 |
|
spermatogenesis |
7 |
|
tmprss2 |
7 |
|
transcription regulation |
7 |
|
upr |
7 |
|
viral variants |
7 |
|
virology |
7 |
|
zika virus |
7 |
|
adult |
6 |
|
animal |
6 |
|
animals |
6 |
|
clr |
6 |
|
common marmoset |
6 |
|
enterovirus |
6 |
|
flow cytometry |
6 |
|
hsp90β |
6 |
|
intestinal |
6 |
|
kaletra |
6 |
|
lopinavir |
6 |
|
mers |
6 |
|
middle aged |
6 |
|
mincle |
6 |
|
mycophenolate |
6 |
|
nucleoprotein |
6 |
|
organoids |
6 |
|
platform |
6 |
|
primate |
6 |
|
proinflammatory response |
6 |
|
rlr |
6 |
|
treatment |
6 |
|
acly |
5 |
|
amino acid substitution - genetics |
5 |
|
antiviral peptide |
5 |
|
b cell |
5 |
|
b-lymphocytes - cytology - immunology - metabolism |
5 |
|
cccdna |
5 |
|
cell line |
5 |
|
cell line, tumor |
5 |
|
cell movement - immunology |
5 |
|
chemokine cxcl13 - biosynthesis - immunology |
5 |
|
chi-square distribution |
5 |
|
delta |
5 |
|
disease susceptibility |
5 |
|
down-regulation |
5 |
|
eif4g1 |
5 |
|
gene deletion |
5 |
|
gene expression profiling |
5 |
|
gene frequency |
5 |
|
genotype |
5 |
|
h5n1 influenza virus |
5 |
|
hbx |
5 |
|
hela cells |
5 |
|
hepatitis b, chronic - genetics |
5 |
|
hepatitis b, chronic - genetics - virology |
5 |
|
host−virus interaction |
5 |
|
ifngr1 |
5 |
|
il-17 |
5 |
|
influenza a virus, h5n1 subtype - immunology - pathogenicity |
5 |
|
influenza, human - immunology - pathology - virology |
5 |
|
interleukin-17 - deficiency - genetics - immunology |
5 |
|
logistic models |
5 |
|
luciferases - genetics - metabolism |
5 |
|
luminescent measurements |
5 |
|
lung - immunology - pathology - virology |
5 |
|
lung infection |
5 |
|
metabolomics |
5 |
|
mice, inbred c57bl |
5 |
|
mice, knockout |
5 |
|
mutation, missense |
5 |
|
odds ratio |
5 |
|
orthomyxoviridae infections - immunology - mortality - pathology - virology |
5 |
|
point mutation |
5 |
|
polymorphism, restriction fragment length |
5 |
|
promoter activity |
5 |
|
promoter regions, genetic - genetics |
5 |
|
protein stability |
5 |
|
receptor, interferon alpha-beta - biosynthesis - genetics |
5 |
|
receptors, cxcr5 - biosynthesis - immunology |
5 |
|
receptors, interferon - genetics |
5 |
|
sequence analysis, dna |
5 |
|
sirt1 |
5 |
|
sirtuin |
5 |
|
survival rate |
5 |
|
tat |
5 |
|
transfection |
5 |
|
weight loss |
5 |
|
adolescent |
4 |
|
antibodies, viral - blood |
4 |
|
antigens, cd55 - genetics - immunology |
4 |
|
asian continental ancestry group |
4 |
|
balb/c mice |
4 |
|
disease prevalence |
4 |
|
european continental ancestry group |
4 |
|
fluorescent antibody technique |
4 |
|
genetic susceptibility |
4 |
|
hong kong - epidemiology |
4 |
|
influenza a virus, h1n1 subtype - immunology - pathogenicity |
4 |
|
influenza, human - genetics - immunology - pathology - virology |
4 |
|
multifactor dimensionality reduction |
4 |
|
neutralization tests |
4 |
|
panenza vaccine |
4 |
|
pb2-k389r |
4 |
|
pb2-v598t/i |
4 |
|
pcr-rflp |
4 |
|
polymorphism, genetic |
4 |
|
sars virus - immunology |
4 |
|
severe acute respiratory syndrome - epidemiology - immunology - virology |
4 |
|
virulence |
4 |
|
virus-like particle |
4 |
|
h5n1 |
3 |
|
mammal |
3 |
|
receptor binding |
3 |
|
1-np |
2 |
|
adult stem cell |
2 |
|
aged |
2 |
|
antiviral agents - metabolism - pharmacology - toxicity |
2 |
|
base sequence |
2 |
|
case-control studies |
2 |
|
cell communication |
2 |
|
chronic hepatitis b infection |
2 |
|
cl-385319 |
2 |
|
cross protection |
2 |
|
cytokines - biosynthesis |
2 |
|
dendritic cells - immunology |
2 |
|
dna, viral - genetics |
2 |
|
dna-binding proteins - drug effects - genetics - physiology |
2 |
|
dogs |
2 |
|
functional deficits |
2 |
|
gene expression regulation, viral - drug effects - physiology |
2 |
|
genes, mhc class ii |
2 |
|
h5n1 influenza a virus |
2 |
|
ha2 |
2 |
|
hbv |
2 |
|
hek293 cells |
2 |
|
hemagglutinin glycoproteins, influenza virus - chemistry - metabolism |
2 |
|
hepatitis b antibodies - blood |
2 |
|
hepatitis b vaccines - administration & dosage |
2 |
|
hepatitis b virus - genetics - isolation & purification |
2 |
|
hepatitis b virus - genetics - physiology |
2 |
|
hepatitis b, chronic - immunology - virology |
2 |
|
human airway organoids |
2 |
|
hydrocarbons, fluorinated - metabolism - pharmacology - toxicity |
2 |
|
immunoglobulin fc fragments - chemistry - immunology |
2 |
|
influenza a virus, h5n1 subtype - chemistry - immunology |
2 |
|
influenza a virus, h5n1 subtype - drug effects - metabolism - physiology |
2 |
|
influenza vaccines |
2 |
|
kruppel-like transcription factors - drug effects - genetics - physiology |
2 |
|
lymphocyte activation |
2 |
|
maldi-msi |
2 |
|
mf59 |
2 |
|
models, molecular |
2 |
|
monocytes - immunology |
2 |
|
multimodal imaging analysis |
2 |
|
nuclear proteins - drug effects - genetics - physiology |
2 |
|
omicron sublineage ba.5 |
2 |
|
piperidines - metabolism - pharmacology - toxicity |
2 |
|
protein conformation |
2 |
|
subunit vaccines |
2 |
|
t cells |
2 |
|
t-lymphocytes - immunology |
2 |
|
vaccines, synthetic - chemistry - immunology |
2 |
|
virus entry inhibitor |
2 |
|
virus internalization - drug effects |
2 |
